1h Free Analyst Time
The acute ischemic stroke therapeutics market is forecasted to grow by USD 1.74 billion during 2023-2028, accelerating at a CAGR of 6.1% during the forecast period. The report on the acute ischemic stroke therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of cardiovascular diseases, increasing adoption of direct oral anticoagulants, and increasing prevalence of sedentary lifestyles.
The acute ischemic stroke therapeutics market is segmented as below:
By Type
- Thrombolytics
- Anticoagulants
- Antiplatelets
- Antihypertensives
- Others
By Distribution Channel
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the acute ischemic stroke therapeutics market covers the following areas:
- Acute Ischemic Stroke Therapeutics Market sizing
- Acute Ischemic Stroke Therapeutics Market forecast
- Acute Ischemic Stroke Therapeutics Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global acute ischemic stroke therapeutics market: Amgen Inc., AstraZeneca Plc, Athersys Inc., Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., F. Hoffmann La Roche Ltd., Johnson and Johnson Services Inc., Medtronic PLC, Merck and Co. Inc., NoNO Inc., Pfizer Inc., SanBio Co. Ltd., Sanofi SA, Stryker Corp., and Teva Pharmaceutical Industries Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is integrating genomic and clinical data through translational bioinformatics in acute ischemic stroke management."
According to the report, one of the major drivers for this market is the rising prevalence of cardiovascular diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Amgen Inc.
- AstraZeneca Plc
- Athersys Inc.
- Bayer AG
- Biogen Inc.
- Boehringer Ingelheim International GmbH
- Bristol Myers Squibb Co.
- Daiichi Sankyo Co. Ltd.
- F. Hoffmann La Roche Ltd.
- Johnson and Johnson Services Inc.
- Medtronic PLC
- Merck and Co. Inc.
- NoNO Inc.
- Pfizer Inc.
- SanBio Co. Ltd.
- Sanofi SA
- Stryker Corp.
- Teva Pharmaceutical Industries Ltd.
